Source: Annual Congress 2007 - Sarcoidosis: various aspects
Disease area: Interstitial lung diseases, Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Rapti, I. Nikolopoulos, C. Papamichail, A. Paridou, A. Kyrkou, E. Gialafos, C. Triantafyllidis, O. Anagnostopoulou, C. Kostopoulos (Athens, Greece). Vascular dysfunction in patients with pulmonary sarcoidosis. Eur Respir J 2007; 30: Suppl. 51, 804

Member's Comments

No comment yet.

Related content which might interest you: Vascular dysfunction and systemic inflammation in patients with COPD Source: Annual Congress 2011 - COPD: human studies Year: 2011 Pulmonary hypertension and endothelial dysfunction in patients with COPD Source: Eur Respir J 2007; 30: Suppl. 51, 605s Year: 2007 Endothelial dysfunction at the patients with COPD with pulmonary hypertension Source: Eur Respir J 2001; 18: Suppl. 33, 415s Year: 2001 Endothelial dysfunction of patients with pulmonary hypertension Source: Eur Respir J 2002; 20: Suppl. 38, 25s Year: 2002 A vasomotor form of the endothelial dysfunction of the microvasculature in patients with a chronic obstructive pulmonary disease, and in combination with the pulmonary embolism Source: International Congress 2015 – Pulmonary hypertension in lung disease Year: 2015 Correction of endothelial dysfunction in patients with pulmonary diseases Source: Annual Congress 2008 - Sarcoidosis and other interstitial lung diseases Year: 2008 Vascular, pulmonary and cardiac involvement in Behcet’s disease Source: Eur Respir J 2004; 24: Suppl. 48, 279s Year: 2004 Pulmonary hypertension and endothelial dysfunction in patients with bronchial asthma Source: Annual Congress 2008 - Pulmonary vascular disease and other pulmonary conditions: miscellaneous Year: 2008 Endothelial and platelet dysfunction in pulmonary hypertension due to sarcoidosis Source: Annual Congress 2008 - Pulmonary vascular biology Year: 2008 Endothelial dysfunction in patients with chronic obstructive pulmonary disease Source: Annual Congress 2011 - Pulmonary hypertension in hypoxic lung disease Year: 2011 Pulmonary endothelial dysfunction in chronic obstructive pulmonary disease Source: ERS Research Seminar 2016 - Pulmonary Vascular Endothelium: Orchestra Conductor in Respiratory Diseases - Highlights from Basic Research to Therapy Year: 2016 Pulmonary hypertension in patients with idiopathic pulmonary fibrosis Source: Eur Respir Mon 2012; 57: 148-160 Year: 2012 Diagnosis of pulmonary arterial hypertension in patients with idiopathic pulmonary fibrosis Source: Eur Respir J 2005; 26: Suppl. 49, 335s Year: 2005 Pulmonary vascular and cardiac impairment in interstitial lung disease Source: Eur Respir Rev 2017; 26: 160128 Year: 2017 Sildenafil inhibit dose-dependently profibrotic and remodelling effects of TGFbeta1 on pulmonary arteries from patients with idiopathic pulmonary fibrosis (IPF) Source: International Congress 2014 – Pulmonary hypertension in lung disease Year: 2014 Pulmonary arterial hypertension in scleroderma – manifestation of systemic endothelial dysfunction Source: Eur Respir J 2006; 28: Suppl. 50, 548s Year: 2006 Effect of pulmonary-specific vasodilator therapy in patients with chronic obstructive pulmonary disease and pulmonary hypertension. A retrospective analysis Source: International Congress 2014 – Pulmonary hypertension in lung disease Year: 2014 Relation between pulmonary arterial remodeling and parenchymal disease in severe COPD and interstitial lung disease patients Source: International Congress 2014 – Pulmonary hypertension in lung disease Year: 2014 Pulmonary hypertension associated with sarcoidosis Source: Eur Respir Mon 2012; 57: 166-181 Year: 2012 Assessment of platelet dysfunction in patients with pulmonary arterial hypertension Source: International Congress 2016 – Pulmonary hypertension: the clinic I Year: 2016